Untreated Adult Acute Lymphoblastic Leukemia Active Not Recruiting Phase 2 Trials for Rituximab (DB00073)

Indication	Status	Phase
DBCOND0029290 (Untreated Adult Acute Lymphoblastic Leukemia)	Active Not Recruiting	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT01424982	Combination Chemotherapy and Ponatinib Hydrochloride in Treating Patients With Acute Lymphoblastic Leukemia	Treatment	Cortisone (DB14681) Cyclophosphamide (DB00531) Cytarabine (DB00987) Daunorubicin (DB00694) Dexamethasone (DB01234) Doxorubicin (DB00997) Methopterin (DB16620) Methotrexate (DB00563) Ponatinib (DB08901) Prednisone (DB00635) Rituximab (DB00073) Sulfate ion (DB14546) Vincristine (DB00541)